Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 7, Issue 2, 2002, Pages 81-88

  Sticherling, Christian ^a   Tada, Hiroshi ^b   Hsu, William ^b   Bares, Anton C ^b   Oral, Hakan ^b   Pelosi, Frank ^b   Knight, Bradley P ^b   Strickberger, S Adam ^b   Morady, Fred ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atrial fibrillation; Cardioversion; Diltiazem; Esmolol

Indexed keywords

DILTIAZEM; ESMOLOL; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; PROPANOLAMINE DERIVATIVE;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVERSION; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HEART CYCLE; HUMAN; MALE; PRIORITY JOURNAL; SINUS RHYTHM; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; TIME;

ADULT; ATRIAL FIBRILLATION; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; TIME FACTORS;

EID: 0036017516     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840200700204     Document Type: Article

References (31)

1. Ventricular rate control and exercise performance in chronic atrial fibrillation: Effects of diltiazem and verapamil
2. Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use, 1980- 1996
3. Pharmacologic management of atrial fibrillation: Current therapeutic strategies
4. Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation
5. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs
6. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation
7. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness
8. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation
9. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
10. Basic pharmacology of esmolol
11. Clinical rationale for the use of an ultra-short acting beta-blocker: Esmolol
12. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure
13. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias
14. Esmolol: A new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias
15. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation
16. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium
17. Properties of human atrial 1Ca at physiological temperatures and relevance to action potential
18. Rate-dependent effects of diltiazem on human atrioventricular nodal properties
19. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: Demonstration and characterization in anesthetized dogs
20. Frequency-dependent effects of verapamil on atrioventricular nodal conduction in man
21. Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties
22. Differential efficacy of L-and T-type calcium channel blockers in preventing tachy-cardia-induced atrial remodeling in dogs
23. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
24. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect
25. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery
26. Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation
27. Verapamil reduces tachycardia-induced electrical remodeling of the atria
28. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
29. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
30. Effect of verapamil on immediate recurrence of atrial fibrillation
31. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm